Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
62
COO Quote, Financials, Valuation and Earnings
Last price:
$81.36
Seasonality move
:
7.71%
Day range:
$81.86 - $82.52
52-week range:
$61.78 - $100.24
Dividend yield:
0%
P/E ratio:
43.74x
P/S ratio:
4.01x
P/B ratio:
1.95x
Volume:
1.1M
Avg. volume:
3.2M
1-year change:
-10.85%
Market cap:
$16.1B
Revenue:
$4.1B
EPS (TTM):
$1.87
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
COO
The Cooper Cos., Inc.
|
$1.1B | $1.11 | 6.12% | 98.42% | $90.50 |
|
KIDS
OrthoPediatrics Corp.
|
$59.3M | -$0.31 | 12.55% | -54.72% | $24.13 |
|
LUCY
Innovative Eyewear, Inc.
|
$1.2M | -$0.43 | 73.74% | -50.4% | $3.00 |
|
MMSI
Merit Medical Systems, Inc.
|
$388.3M | $0.95 | 9.51% | 106.1% | $103.60 |
|
NXGL
NexGel, Inc.
|
$3.2M | -$0.09 | 6.54% | -22.68% | $6.00 |
|
STAA
STAAR Surgical Co.
|
$75.5M | $0.15 | 54.33% | 39.51% | $26.56 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
COO
The Cooper Cos., Inc.
|
$81.96 | $90.50 | $16.1B | 43.74x | $0.01 | 0% | 4.01x |
|
KIDS
OrthoPediatrics Corp.
|
$17.76 | $24.13 | $445.4M | -- | $0.00 | 0% | 1.82x |
|
LUCY
Innovative Eyewear, Inc.
|
$1.00 | $3.00 | $5.3M | -- | $0.00 | 0% | 1.35x |
|
MMSI
Merit Medical Systems, Inc.
|
$88.14 | $103.60 | $5.2B | 45.11x | $0.00 | 0% | 3.62x |
|
NXGL
NexGel, Inc.
|
$1.61 | $6.00 | $13.1M | -- | $0.00 | 0% | 1.05x |
|
STAA
STAAR Surgical Co.
|
$23.09 | $26.56 | $1.1B | 49.73x | $0.00 | 0% | 4.97x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
COO
The Cooper Cos., Inc.
|
25.25% | -0.042 | 20.32% | 0.89x |
|
KIDS
OrthoPediatrics Corp.
|
22.39% | -0.306 | 21.68% | 3.39x |
|
LUCY
Innovative Eyewear, Inc.
|
1.01% | 5.916 | 1.04% | 9.17x |
|
MMSI
Merit Medical Systems, Inc.
|
34.93% | 0.094 | 16.64% | 2.67x |
|
NXGL
NexGel, Inc.
|
38.1% | 1.021 | 15.76% | 0.82x |
|
STAA
STAAR Surgical Co.
|
9.96% | 0.664 | 2.95% | 4.10x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
COO
The Cooper Cos., Inc.
|
$601M | $140.4M | 3.45% | 4.56% | 13.18% | $149.9M |
|
KIDS
OrthoPediatrics Corp.
|
$40M | -$4.9M | -10.3% | -12.83% | -7.95% | -$3.4M |
|
LUCY
Innovative Eyewear, Inc.
|
$244.8K | -$1.9M | -79.57% | -80% | -287.5% | -$1.5M |
|
MMSI
Merit Medical Systems, Inc.
|
$186.5M | $42.8M | 5.28% | 8.28% | 11.13% | $51.5M |
|
NXGL
NexGel, Inc.
|
$1.2M | -$725K | -33.25% | -51.15% | -24.71% | -$793K |
|
STAA
STAAR Surgical Co.
|
$76.6M | $44.5M | -23.38% | -25.83% | 46.96% | $1.8M |
The Cooper Cos., Inc. vs. Competitors
-
Which has Higher Returns COO or KIDS?
OrthoPediatrics Corp. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of -19.22%. The Cooper Cos., Inc.'s return on equity of 4.56% beat OrthoPediatrics Corp.'s return on equity of -12.83%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.56.42% $0.43 $11B KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M -
What do Analysts Say About COO or KIDS?
The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 10.42%. On the other hand OrthoPediatrics Corp. has an analysts' consensus of $24.13 which suggests that it could grow by 35.84%. Given that OrthoPediatrics Corp. has higher upside potential than The Cooper Cos., Inc., analysts believe OrthoPediatrics Corp. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 KIDSOrthoPediatrics Corp.4 1 0 -
Is COO or KIDS More Risky?
The Cooper Cos., Inc. has a beta of 1.028, which suggesting that the stock is 2.836% more volatile than S&P 500. In comparison OrthoPediatrics Corp. has a beta of 1.091, suggesting its more volatile than the S&P 500 by 9.108%.
-
Which is a Better Dividend Stock COO or KIDS?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. OrthoPediatrics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. OrthoPediatrics Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or KIDS?
The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than OrthoPediatrics Corp. quarterly revenues of $61.3M. The Cooper Cos., Inc.'s net income of $84.6M is higher than OrthoPediatrics Corp.'s net income of -$11.8M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 43.74x while OrthoPediatrics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.01x versus 1.82x for OrthoPediatrics Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.4.01x 43.74x $1.1B $84.6M KIDSOrthoPediatrics Corp.1.82x -- $61.3M -$11.8M
-
Which has Higher Returns COO or LUCY?
Innovative Eyewear, Inc. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of -274.85%. The Cooper Cos., Inc.'s return on equity of 4.56% beat Innovative Eyewear, Inc.'s return on equity of -80%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.56.42% $0.43 $11B LUCYInnovative Eyewear, Inc.36.64% -$0.38 $10.4M -
What do Analysts Say About COO or LUCY?
The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 10.42%. On the other hand Innovative Eyewear, Inc. has an analysts' consensus of $3.00 which suggests that it could grow by 201.05%. Given that Innovative Eyewear, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe Innovative Eyewear, Inc. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 LUCYInnovative Eyewear, Inc.0 0 0 -
Is COO or LUCY More Risky?
The Cooper Cos., Inc. has a beta of 1.028, which suggesting that the stock is 2.836% more volatile than S&P 500. In comparison Innovative Eyewear, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or LUCY?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Innovative Eyewear, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. Innovative Eyewear, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or LUCY?
The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than Innovative Eyewear, Inc. quarterly revenues of $668.1K. The Cooper Cos., Inc.'s net income of $84.6M is higher than Innovative Eyewear, Inc.'s net income of -$1.8M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 43.74x while Innovative Eyewear, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.01x versus 1.35x for Innovative Eyewear, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.4.01x 43.74x $1.1B $84.6M LUCYInnovative Eyewear, Inc.1.35x -- $668.1K -$1.8M
-
Which has Higher Returns COO or MMSI?
Merit Medical Systems, Inc. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of 7.22%. The Cooper Cos., Inc.'s return on equity of 4.56% beat Merit Medical Systems, Inc.'s return on equity of 8.28%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.56.42% $0.43 $11B MMSIMerit Medical Systems, Inc.48.54% $0.46 $2.4B -
What do Analysts Say About COO or MMSI?
The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 10.42%. On the other hand Merit Medical Systems, Inc. has an analysts' consensus of $103.60 which suggests that it could grow by 17.54%. Given that Merit Medical Systems, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe Merit Medical Systems, Inc. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 MMSIMerit Medical Systems, Inc.4 1 0 -
Is COO or MMSI More Risky?
The Cooper Cos., Inc. has a beta of 1.028, which suggesting that the stock is 2.836% more volatile than S&P 500. In comparison Merit Medical Systems, Inc. has a beta of 0.617, suggesting its less volatile than the S&P 500 by 38.251%.
-
Which is a Better Dividend Stock COO or MMSI?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Merit Medical Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. Merit Medical Systems, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or MMSI?
The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than Merit Medical Systems, Inc. quarterly revenues of $384.3M. The Cooper Cos., Inc.'s net income of $84.6M is higher than Merit Medical Systems, Inc.'s net income of $27.8M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 43.74x while Merit Medical Systems, Inc.'s PE ratio is 45.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.01x versus 3.62x for Merit Medical Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.4.01x 43.74x $1.1B $84.6M MMSIMerit Medical Systems, Inc.3.62x 45.11x $384.3M $27.8M
-
Which has Higher Returns COO or NXGL?
NexGel, Inc. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of -22.05%. The Cooper Cos., Inc.'s return on equity of 4.56% beat NexGel, Inc.'s return on equity of -51.15%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.56.42% $0.43 $11B NXGLNexGel, Inc.40.93% -$0.08 $8.8M -
What do Analysts Say About COO or NXGL?
The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 10.42%. On the other hand NexGel, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 272.67%. Given that NexGel, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe NexGel, Inc. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 NXGLNexGel, Inc.0 0 0 -
Is COO or NXGL More Risky?
The Cooper Cos., Inc. has a beta of 1.028, which suggesting that the stock is 2.836% more volatile than S&P 500. In comparison NexGel, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock COO or NXGL?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. NexGel, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. NexGel, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or NXGL?
The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than NexGel, Inc. quarterly revenues of $2.9M. The Cooper Cos., Inc.'s net income of $84.6M is higher than NexGel, Inc.'s net income of -$647K. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 43.74x while NexGel, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.01x versus 1.05x for NexGel, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.4.01x 43.74x $1.1B $84.6M NXGLNexGel, Inc.1.05x -- $2.9M -$647K
-
Which has Higher Returns COO or STAA?
STAAR Surgical Co. has a net margin of 7.94% compared to The Cooper Cos., Inc.'s net margin of 9.38%. The Cooper Cos., Inc.'s return on equity of 4.56% beat STAAR Surgical Co.'s return on equity of -25.83%.
Company Gross Margin Earnings Per Share Invested Capital COOThe Cooper Cos., Inc.56.42% $0.43 $11B STAASTAAR Surgical Co.80.89% $0.18 $392.9M -
What do Analysts Say About COO or STAA?
The Cooper Cos., Inc. has a consensus price target of $90.50, signalling upside risk potential of 10.42%. On the other hand STAAR Surgical Co. has an analysts' consensus of $26.56 which suggests that it could grow by 15.04%. Given that STAAR Surgical Co. has higher upside potential than The Cooper Cos., Inc., analysts believe STAAR Surgical Co. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings COOThe Cooper Cos., Inc.6 7 1 STAASTAAR Surgical Co.1 9 0 -
Is COO or STAA More Risky?
The Cooper Cos., Inc. has a beta of 1.028, which suggesting that the stock is 2.836% more volatile than S&P 500. In comparison STAAR Surgical Co. has a beta of 1.000, suggesting its less volatile than the S&P 500 by 0.048000000000004%.
-
Which is a Better Dividend Stock COO or STAA?
The Cooper Cos., Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. STAAR Surgical Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. The Cooper Cos., Inc. pays -- of its earnings as a dividend. STAAR Surgical Co. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios COO or STAA?
The Cooper Cos., Inc. quarterly revenues are $1.1B, which are larger than STAAR Surgical Co. quarterly revenues of $94.7M. The Cooper Cos., Inc.'s net income of $84.6M is higher than STAAR Surgical Co.'s net income of $8.9M. Notably, The Cooper Cos., Inc.'s price-to-earnings ratio is 43.74x while STAAR Surgical Co.'s PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for The Cooper Cos., Inc. is 4.01x versus 4.97x for STAAR Surgical Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income COOThe Cooper Cos., Inc.4.01x 43.74x $1.1B $84.6M STAASTAAR Surgical Co.4.97x 49.73x $94.7M $8.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.92% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 2.76% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 8.14% over the past day.
